MCKESSON BISMUTH- bismuth subsalicylate tablet, chewable

McKesson Bismuth by

Drug Labeling and Warnings

McKesson Bismuth by is a Otc medication manufactured, distributed, or labeled by McKesson Medical-Surgical, Unifirst First Aid Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENT

Active ingredient (in each tablet)

Bismuth Subsalicylate 262 mg

(each tablet contains 102 mg salicylate)

PURPOSE

Purpose antidiarrheal/antacid

INDICATIONS & USAGE

Uses

relieves

• traveler's diarrhea
• diarrhea
• upset stomach reliever due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching

fullness

WARNINGS

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's Syndrome a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are:

• allergic to salicylates (including aspirin)
• taking other salicylate products

DO NOT USE

Do not use if you have

• bloody or black stool
• an ulcer
• a bleeding problem

ASK DOCTOR

Ask a doctor before use if you have​

• fever
• mucus in the stool

ASK DOCTOR/PHARMACIST

Ask a doctor or pharmacist if you are taking any drug for

• anticoagulation (thinning of the blood)
• diabetes
• gout
• arthritis

WHEN USING

When using this product a temporary and harmless darkening of the tongue and/or stool may occur.

STOP USE

Stop use and ask a doctor if

• symptoms get worse or lasts more than 2 days
• ringing in the ears or loss of hearing occurs
• diarrhea lasts more than 2 days

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. In case of accidental overdose, contact a physician or poison control center right away (1-800-222-1222).

DOSAGE & ADMINISTRATION

Directions

• chew or dissolve in mouth
• drink plenty of clear fluids to help prevent dehydration, which may accompany diarrhea

Adults and children: (12 years and over)

• chew 2 tablets every 1/2 to 1 hour as needed
• do not exceed 16 tablets in 24 hours
• use until diarrhea stops but not more than 2 days

Children under 12 years:

Ask a doctor

OTHER SAFETY INFORMATION

Other information

• phenylketonurics: contains phenylalanine 1.1 mg per tablet
• calcium content per tablet: 73 mg
• store at room temperature 59°-86°F (15°-30°C)
• tamper-evident sealed packets
• do not use any opened or torn packets

INACTIVE INGREDIENT

Inactive ingredients

acacia gum, aspartame, calcium carbonate, D&C red #27 aluminum lake, dextrates, magnesium stearate, maltodextrin, microcrystalline cellulose, peppermint flavor, silicon dioxide

QUESTIONS

Questions or comments? 1-800-777-4908

PRINCIPAL DISPLAY PANEL

NDC: 68599-4744-7

McKesson

Bismuth Tablets 262 mg

Bismuth Suybsalicylate

2 Per Pack | 100 Packs Per Box

MFR # 82473

INGREDIENTS AND APPEARANCE

MCKESSON BISMUTH 
bismuth subsalicylate tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 68599-4744
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ, BISMUTH CATION - UNII:ZS9CD1I8YE)	BISMUTH SUBSALICYLATE	262 mg

Inactive Ingredients
Ingredient Name	Strength
DEXTRATES (UNII: G263MI44RU)
MAGNESIUM STEARATE (UNII: 70097M6I30)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
ACACIA (UNII: 5C5403N26O)
ASPARTAME (UNII: Z0H242BBR1)
CALCIUM CARBONATE (UNII: H0G9379FGK)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
D&C RED NO. 27 (UNII: 2LRS185U6K)

Product Characteristics
Color	pink	Score	no score
Shape	ROUND	Size	16mm
Flavor	PEPPERMINT	Imprint Code	RH;046
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 68599-4744-7	100 in 1 BOX	03/01/2022
1		2 in 1 PACKET; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part335	03/01/2022

Labeler - McKesson Medical-Surgical (023904428)

Registrant - Unifirst First Aid Corporation (832947092)